OOIR: Observatory of International Research

Papers

(The TQCC of Gut Pathogens is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
A fatal case of Vibrio cholerae-associated diarrhea and bacteremia in a 30-year-old carrier of beta-thalassemia	92
Clonal and horizontal transmission of carbapenem-resistant Enterobacterales strains and genes via flies	78
Comprehensive evaluation and progress of colorectal cancer screening methods	44
Assessing the impact of storage time on the stability of stool microbiota richness, diversity, and composition	43
Equol: a metabolite of gut microbiota with potential antitumor effects	40
Stunting is associated with persistent and transferable alterations in the gut microbiome	35
A case–control study of the association between the gut microbiota and colorectal cancer: exploring the roles of diet, stress, and race	31
Analysis of antimicrobial resistance patterns and genetic mutations in Helicobacter pylori from West Bengal, India depicting escalating clarithromycin and high levofloxacin resistance	30
Systemic IgG responses to glycosylated mucinase YghJ after experimental enterotoxigenic Escherichia coli infection	30
A monoclonal antibody collection for C. difficile typing ?	29
Dietary patterns drive loss of fiber-foraging species in the celiac disease patients gut microbiota compared to first-degree relatives	29
The emerging role of neutrophilic extracellular traps in intestinal disease	29
Significant abundance of bacterial flagellin and expression of its surface localized receptor toll-like receptor 5 and cytokine interleukin-22 in South African infants with poor oral rotavirus vaccine	29
Invasion of intestinal cells by Staphylococcus warneri, a member of the human gut microbiota	28
Translocating lipopolysaccharide correlates with the severity of enterovirus A71-induced HFMD by promoting pro-inflammation and viral IRES activity	28
Characteristics of ESBL-positive Klebsiella pneumoniae isolated from paired children with and without diarrhea	26
Intestinal metabolites predict treatment resistance of patients with depression and anxiety	25
Profile of intestinal fungal microbiota in acute pancreatitis patients and healthy individuals	23
The role of non-Helicobacter pylori bacteria in the pathogenesis of gastroduodenal diseases	22
Elucidating antibiofilm as well as photocatalytic disinfection potential of green synthesized nanosilver against multi-drug-resistant bacteria and its photodegradation ability of cationic dyes	22
Impact of invasive infections on clinical outcomes in acute pancreatitis: early predictive factors and implications for prophylactic anti-infective therapy	21
Retrospective analysis of Clostridioides difficile and other intestinal infections in patients with Crohn’s disease and ulcerative colitis in the tertiary hospital in Poland. POLIBD survey results	21
Fecal microbiome alterations of mice following immunization with gold nanoparticle vaccines against enterohemorrhagic Escherichia coli	20
Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease	19
Gut microbiota alterations and their association with tumorigenic pathways in colorectal cancer: insights from a pooled analysis of 109 microbiome datasets	18

Tripartite interplay: immune reconstitution dynamics in AIDS, gut microbiota, and Helicobacter pylori infection: current advances and therapeutic prospects	18
Fusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer	18
Pathogenetic detection, retrospective and pathogenicity analysis of a fatal case of Vibrio vulnificus in Shenzhen, China	18
A systematic review and meta-analysis of protozoan parasite infections among patients with mental health disorders: an overlooked phenomenon	17
A prospective investigation into the association between the gut microbiome composition and cognitive performance among healthy young adults	17
Fecal glycoprotein 2 is a marker of gut microbiota dysbiosis and systemic inflammation	17
Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein?	16
Genomes of Vibrio metoecus co-isolated with Vibrio cholerae extend our understanding of differences between these closely related species	16
Genome insights of Enterococcus raffinosus CX012922, isolated from the feces of a Crohn’s disease patient	15
Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms	15
Antimicrobial growth promoters approved in food-producing animals in South Africa induce shiga toxin-converting bacteriophages from Escherichia coli O157:H7.	15
Tissue-specific transcriptomic adaptation in three strains of chickens during coinfections with parasites	15
Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load	15
16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population	13
Prevalence of intestinal parasites and Helicobacter pylori coinfection, and contributing factors among patients with gastrointestinal manifestations at Addis Zemen primary hospital, Northwest Ethiopia	13
Risk factors and clinical outcomes associated with multiple as opposed to single pathogens detected on the gastrointestinal disease polymerase chain reaction assay	13
Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer	12
Overview of pathogenic Escherichia coli, with a focus on Shiga toxin-producing serotypes, global outbreaks (1982–2024) and food safety criteria	12
Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report	12
Bacteroides- and Prevotella-enriched gut microbial clusters associate with metabolic risks	11
Determinants of Campylobacter species diversity in infants and association with family members, livestock, and household environments in rural Eastern Ethiopia	11
The immune-adjunctive potential of recombinant LAB vector expressing murine IFNλ3 (MuIFNλ3) against Type A Influenza Virus (IAV) infection	11
A triad of gut dysbiosis, dysregulated immunity, and ‘leaky’ gut characterize HCMV associated neonatal cholestasis	11
Metagenomics: a new frontier for routine pathology testing of gastrointestinal pathogens	11
Etiology of diarrheal hospitalizations following rotavirus vaccine implementation and association of enteric pathogens with malnutrition among under-five children in India	10
Bacteremia from streptococcus constellatus revealing a gastrointestinal stromal tumor	10
Genomic insights into zoonotic transmission and antimicrobial resistance in Campylobacter jejuni from farm to fork: a one health perspective	10
Correction: Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms	10
Correlation between gut microbiota composition, enteric infections and linear growth impairment: a case–control study in childhood stunting in Pidie, Aceh, Indonesia	10
Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens	10
Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies	10
Genetic evolution and phylogenetic analysis of porcine epidemic diarrhea virus strains circulating in and outside China with reference to a wild type virulent genotype CHYJ130330 reported from Guangdo	10
High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota	10
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial	10
Salmonella prevalence and serovar distribution in reptiles: a systematic review and meta-analysis	10
Comparison of antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms with and without zinc oxide and antimicrobial usage	10
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial	10
Timing and clinical risk factors for early acquisition of gut pathogen colonization with multidrug resistant organisms in the intensive care unit	10
Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets	9
Development of the gut microbiota during early life in premature and term infants	9
Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection	9
Changes in the gut bacterial communities in colon cancer surgery patients: an observational study	9
Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern India	9
The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis	9
Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials	9
miR-125a-5p regulates the sialyltransferase ST3GAL1 in murine model of human intestinal campylobacteriosis	9
Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma	9
Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes	9